Mirum Pharmaceuticals Inc
NASDAQ:MIRM

Watchlist Manager
Mirum Pharmaceuticals Inc Logo
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
Watchlist
Price: 49.02 USD 1.16% Market Closed
Market Cap: 2.4B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+46%
Revenue
Forecast
+24%
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

MIRM Price Targets Summary
Mirum Pharmaceuticals Inc

Wall Street analysts forecast MIRM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MIRM is 71.74 USD with a low forecast of 55.55 USD and a high forecast of 82.95 USD.

MIRM Lowest Forecast
Wall Street Target
55.55 USD
13% Upside
MIRM Average Forecast
Wall Street Target
71.74 USD
46% Upside
MIRM Highest Forecast
Wall Street Target
82.95 USD
69% Upside
Lowest
Price Target
55.55 USD
13% Upside
Average
Price Target
71.74 USD
46% Upside
Highest
Price Target
82.95 USD
69% Upside
Mirum Pharmaceuticals Inc Competitors:
Price Targets
TSHA
Taysha Gene Therapies Inc
175% Upside
BONEX
Bonesupport Holding AB
69% Upside
NVAX
Novavax Inc
138% Upside
LXRX
Lexicon Pharmaceuticals Inc
278% Upside
TSHA
Taysha Gene Therapies Inc
175% Upside
BONEX
Bonesupport Holding AB
69% Upside
NVAX
Novavax Inc
138% Upside
LXRX
Lexicon Pharmaceuticals Inc
278% Upside
E
206650
EuBiologics Co Ltd
26% Upside
ARGX
argenx SE
36% Upside
SLNO
Soleno Therapeutics Inc
37% Upside
9688
Zai Lab Ltd
12% Upside

Revenue
Forecast

Revenue Estimate
Mirum Pharmaceuticals Inc

The compound annual growth rate of Mirum Pharmaceuticals Inc's revenue for the next 3 years is 24%.

N/A
Past Growth
24%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Mirum Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Mirum Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
What are analyst estimates?

See Also

Summary
MIRM intrinsic value, competitors valuation, and company profile.
DCF Valuation
MIRM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MIRM stock valuation using valuation multiples.
Wall Street Estimates
MIRM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MIRM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MIRM's stock price target?
Price Target
71.74 USD

According to Wall Street analysts, the average 1-year price target for MIRM is 71.74 USD with a low forecast of 55.55 USD and a high forecast of 82.95 USD.

What is Mirum Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
24%

The compound annual growth rate of Mirum Pharmaceuticals Inc's revenue for the next 3 years is 24%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 261,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.